Treatment
Treatment A clinical trials
We’re tracking 8,312 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT06587477Recruiting
Fertility in Men Who Had Cancer as Children
This study examines testicular function and semen quality in men who were treated for cancer before age 18 and are now in remission. It aims to understand how childhood cancer treatments affect long-term fertility.
Hong KongAges 18–50 - NCT06603376RecruitingPhase 2
Drug combo for BRAF-mutated advanced colorectal cancer
This trial tests a combination of four drugs (irinotecan liposome, fluorouracil, folinic acid, vermofenib, and cetuximab) as a first treatment for people with advanced colorectal cancer that has a specific BRAF V600E mutation. It aims to see if this combination can shrink tumors or slow their growth.
ShanghaiAges 18–80 - NCT06355609RecruitingPhase 2
Targeted therapy for advanced EGFR-mutant lung cancer
This trial tests a combination of two targeted pills (sunvozertinib and anlotinib) as a first treatment for people with advanced lung cancer that has a specific EGFR mutation. It aims to see if this combination works better than current standard treatments.
Changsha, HunanAges 18 years+ - NCT06344052RecruitingPhase 2
SP-002 with Vismodegib for Advanced Basal Cell Cancer
This trial tests a new drug (SP-002) combined with vismodegib for people with locally advanced basal cell carcinoma, a type of skin cancer that can't be treated with surgery or has come back after surgery. The goal is to see if this combination is safe and effective.
Phoenix, ArizonaAges 18 years+ - NCT07748572Recruiting
Tracking safety and performance of brain aneurysm flow diverters
This study collects information from patients in France who are being treated for a brain aneurysm with specific flow diversion devices (p64, p48 MW, or p64 MW). The goal is to confirm that these devices are safe and work well in real-world use, which can help doctors make better treatment decisions.
AmiensAges 18 years+ - NCT07743944Recruiting
Breast cancer second-line treatment patterns in China
This study looks at how doctors in China treat hormone receptor-positive, HER2-negative breast cancer that has spread, when patients are starting their second line of therapy. The goal is to learn more about real-world treatment patterns and results, which may help you and your doctor make more informed treatment decisions.
Nanjing, JiangsuAges 18 years+ - NCT07746206RecruitingEarly Phase 1
Insulin vs hyaluronic acid gel for advanced gum disease
This study compares two treatments applied directly to the gums to see which one better helps severe gum disease (periodontitis) heal. If you have advanced gum disease and haven't had treatment recently, you may be able to join.
CairoAges Any age - NCT06608342RecruitingPhase 2
Stem cell transplant plus CAR-T for high-risk leukemia
This trial tests a combination of your own stem cell transplant and a personalized CAR-T cell therapy called CD19-CAR-T. It is for adults with high-risk acute B-lymphoblastic leukemia whose cancer is in remission after initial chemotherapy, and who are able to receive both treatments safely.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06609447RecruitingPhase 4
Probiotic with vedolizumab for moderate ulcerative colitis
This study tests whether adding a special probiotic (VSL#3) to vedolizumab helps people with moderate ulcerative colitis more than vedolizumab alone. You may qualify if you are already planning to start vedolizumab and haven't responded well enough to other treatments.
Beijing, Beijing MunicipalityAges 18–85 - NCT06609551RecruitingPhase 3
ctDNA-guided chemo choice for elderly colon cancer patients
This trial tests whether using a ctDNA blood test can help choose the best chemotherapy after colon cancer surgery for people aged 70–80. It aims to make treatment more personalized and reduce side effects.
Hangzhou, ZhejiangAges 70–80 - NCT07748988RecruitingPhase 1
Casdatifan for advanced kidney cancer that has stopped responding
This study tests a new pill called casdatifan for people with advanced kidney cancer that has not improved after standard treatments. The goal is to see if the drug can shrink tumors and be safe to take.
Nashville, TennesseeAges 18–100 - NCT07748793Recruiting
Fat grafting for treating chronic tendon pain
This trial injects your own fat into the painful tendon area to help it heal. It is for people with long-lasting tendon pain that has not improved with other treatments like physical therapy or injections.
New York, New YorkAges 18–80 - NCT07748091Recruiting
Brain wave and inflammation markers in shock therapy for depression
This study looks at brain wave patterns and markers of inflammation in people with depression that hasn't improved with other treatments and who are receiving electroconvulsive therapy (ECT, also known as shock therapy). The goal is to understand how these markers might relate to how well ECT works.
Istanbul, BakırköyAges 18–60 - NCT07747896Recruiting
Coordinated primary care team for hard-to-heal wounds
This trial tests whether a team of different healthcare professionals working together in your primary care clinic can help heal stubborn wounds (ulcers) that have not healed with standard care. If you join, you may get more coordinated care and support to help your wound heal.
HillerødAges 18 years+ - NCT07747350Recruiting
Laser vs pain pills for braces pain in Malay women
This study compares a low-level laser treatment with standard painkillers to see which works better for reducing pain from getting braces. It is for Malay women aged 18-33 who have never had braces and are generally healthy.
Kota Bharu, KOTA BHARUAges 18–33 - NCT07741071RecruitingPhase 2
Vitamin B3 supplement for early Alzheimer's disease
This study tests whether a daily supplement (nicotinamide riboside, a form of vitamin B3) can slow the progression of early Alzheimer's disease over two years. It is a randomized, double-blind trial, meaning half the participants will get the supplement and half will get a placebo (a pill with no active ingredient), and neither you nor the doctors will know which you are getting.
BergenAges 50–85 - NCT07749105Recruiting
Cognitive strategies for first-episode psychosis to improve work and school
This study tests a cognitive self-management program to help young people with first-episode psychosis improve their thinking skills and achieve work or school goals. It may help you get back to school or work.
Big Spring, TexasAges 15–32 - NCT07749534Recruiting
Living with spinal deformity: quality of life study
This study follows adults with spinal deformity to understand how the condition and its treatments affect daily life, emotions, and physical function. It aims to improve care and support for people like you.
LeuvenAges 18 years+ - NCT07746778Recruiting
School program to slow nearsightedness in children
This study tests whether a school-based program can help slow the progression of nearsightedness (myopia) in children who are either already nearsighted or at risk of becoming nearsighted. It may help reduce the need for stronger glasses in the future.
Shanghai, Shanghai MunicipalityAges 6–11 - NCT07746804Recruiting
School program to prevent nearsightedness in children
This study tests a school-based program to help prevent nearsightedness (myopia) in children who are not yet nearsighted but have a higher risk of developing it. It uses a simple, non-invasive method called auricular acupressure, which involves placing small seeds on the ear, to see if it can keep eyes healthy and reduce the chance of needing glasses.
Shanghai, Shanghai MunicipalityAges 6–11 - NCT07743424Recruiting
Spinal magnetic therapy for nerve pain from a herniated disc
This study tests a treatment that uses magnetic pulses through the spine to reduce nerve pain caused by a herniated disc pressing on a nerve in your lower back. The goal is to see if this painless, non-invasive therapy can help improve your symptoms.
GizaAges 20–40 - NCT07746336RecruitingPhase 4
Guiding heart ablation with 3D heart mapping
This trial tests a new heart-mapping technique to help doctors treat a fast heart rhythm caused by heart disease. It might improve the precision of the procedure, making it safer and more effective for patients with this condition.
BarcelonaAges 18–99 - NCT07746752Recruiting
School program to prevent nearsightedness in kids with good eye reserve
This study tests whether a school-based program can help prevent nearsightedness (myopia) in children who currently have good distance vision and enough 'eye reserve' (hyperopic reserve) to potentially avoid becoming nearsighted. It focuses on early elementary students to see if simple activities can keep their eyes healthy.
Shanghai, Shanghai MunicipalityAges 6–11 - NCT07745426RecruitingPhase 2
Comparing add-on treatments for rheumatoid arthritis
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
TantaAges 18–70
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.